{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:30:26Z","timestamp":1791970226073,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.jvir.2007.01.025","type":"journal-article","created":{"date-parts":[[2007,3,21]],"date-time":"2007-03-21T10:52:47Z","timestamp":1174474367000},"page":"331-333","source":"Crossref","is-referenced-by-count":29,"title":["Gadolinium-based Contrast Media and the Development of Nephrogenic Systemic Fibrosis in Patients with Renal Insufficiency"],"prefix":"10.1016","volume":"18","author":[{"given":"Rush H.","family":"Chewning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2007.01.025_bib1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2214\/ajr.142.3.619","article-title":"Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent","volume":"142","author":"Weinmann","year":"1984","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jvir.2007.01.025_bib2","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.2214\/ajr.160.6.8388622","article-title":"Gadopentetate dimeglumine as an alternative contrast agent for use in angiography","volume":"16","author":"Kinno","year":"1993","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jvir.2007.01.025_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1148\/radiol.2232010742","article-title":"Gadolinium chelates in angiography and interventional radiology: a useful alternative to iodinated contrast media for angiography","volume":"223","author":"Spinosa","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2007.01.025_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1067\/j.cpradiol.2005.08.002","article-title":"Gadolinium-enhanced computed tomographic angiography: current status","volume":"34","author":"Rosioreanu","year":"2005","journal-title":"Curr Probl Diagn Radiol"},{"key":"10.1016\/j.jvir.2007.01.025_bib5","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.2214\/ajr.173.5.10541129","article-title":"Gadolinium-based contrast agents in angiography and interventional radiology","volume":"173","author":"Spinosa","year":"1999","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jvir.2007.01.025_bib6","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2214\/ajr.167.4.8819369","article-title":"Adverse reactions to gadolinium contrast media: a review of 36 cases","volume":"167","author":"Murphy","year":"1996","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jvir.2007.01.025_bib7","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2214\/ajr.164.3.7863905","article-title":"Fatal reaction to gadopentetate dimeglumine","volume":"164","author":"Jordan","year":"1995","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jvir.2007.01.025_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1148\/radiol.2232010221","article-title":"Are gadolinium-based media really safer than iodinated media for digital subtraction angiography in patients with azotemia?","volume":"223","author":"Nyman","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2007.01.025_bib9","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1007\/s00330-004-2379-0","article-title":"Gadolinium-based contrast media may be nephrotoxic even at approved doses","volume":"14","author":"Thomsen","year":"2004","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jvir.2007.01.025_bib10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/ndt\/gfi304","article-title":"The safety of gadolinium in patients with stage 3 and 4 renal failure","volume":"21","author":"Ergun","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jvir.2007.01.025_bib11","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ndt\/gfk062","article-title":"Gadolinium: a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?","volume":"21","author":"Grobner","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jvir.2007.01.025_bib12","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1681\/ASN.2006060601","article-title":"Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging","volume":"17","author":"Marckmann","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jvir.2007.01.025_bib13","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(00)02694-5","article-title":"Scleromyxoedema-like cutaneous diseases in renal-dialysis patients","volume":"356","author":"Cowper","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jvir.2007.01.025_bib14","unstructured":"U.S. Food and Drug Administration. Public Health Advisory: update on magnetic resonance imaging (mri) contrast agents containing gadolinium and nephrogenic fibrosing dermopathy. Department of Health and Human Services. Available at http:\/\/www.fda.gov. Accessed January 21, 2007."},{"key":"10.1016\/j.jvir.2007.01.025_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2214\/ajr.169.1.9207574","article-title":"Cutaneous nodules, pain, and thrombophlebitis as an adverse reaction to gadolinium contrast media","volume":"169","author":"Murphy","year":"1997","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jvir.2007.01.025_bib16","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1076-6332(99)80114-7","article-title":"Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk: a survey of the American Society of Neuroradiology fellowship directors","volume":"6","author":"Murphy","year":"1999","journal-title":"Acad Radiol"},{"key":"10.1016\/j.jvir.2007.01.025_bib17","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.semarthrit.2005.08.002","article-title":"Description of twelve cases of nephrogenic fibrosing dermopathy and review of the literature","volume":"35","author":"Mendoza","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jvir.2007.01.025_bib18","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archderm.139.7.903","article-title":"Nephrogenic fibrosing dermopathy with systemic involvement","volume":"139","author":"Ting","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jvir.2007.01.025_bib19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/00002281-200311000-00017","article-title":"Nephrogenic fibrosing dermopathy: the first 6 years","volume":"15","author":"Cowper","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jvir.2007.01.025_bib20","unstructured":"Cowper SE. Nephrogenic fibrosing dermopathy [NFD\/NSF Website]. 2001\u20132007. Available at http:\/\/www.icnfdr.org. Accessed January 23, 2007."},{"key":"10.1016\/j.jvir.2007.01.025_bib21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.ajkd.2005.08.008","article-title":"Nephrogenic systemic fibrosis: the nosological and conceptual evolution of nephrogenic fibrosing dermopathy","volume":"46","author":"Cowper","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jvir.2007.01.025_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaad.2006.10.047","article-title":"Gadolinium is detectable within the tissues of patients with nephrogenic systemic fibrosis","volume":"56","author":"High","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jvir.2007.01.025_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2006.10.048","article-title":"Gadolinium deposition in nephrogenic fibrosing dermopathy","volume":"56","author":"Boyd","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jvir.2007.01.025_bib24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1472-8206.2006.00447.x","article-title":"Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review","volume":"20","author":"Idee","year":"2006","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.jvir.2007.01.025_bib25","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00004424-199610000-00003","article-title":"Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media","volume":"31","author":"Puttagunta","year":"1996","journal-title":"Invest Radiol"},{"key":"10.1016\/j.jvir.2007.01.025_bib26","unstructured":"Dharnidharka VR, Wesson SK, Fennell RS. Gadolinium and nephrogenic fibrosing dermopathy in pediatric patients. Available at http:\/\/www.springerlink.com\/content\/1432-198X. Accessed January 23, 2007."},{"key":"10.1016\/j.jvir.2007.01.025_bib27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1076-6332(98)80191-8","article-title":"Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis","volume":"5","author":"Joffe","year":"1998","journal-title":"Acad Radiol"},{"key":"10.1016\/j.jvir.2007.01.025_bib28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0730-725X(03)00081-X","article-title":"An investigation of the toxicity of gadolinium-based MRI contrast agents using neutron activation analysis","volume":"21","author":"Bartolini","year":"2003","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.jvir.2007.01.025_bib29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/028418501127346756","article-title":"Safety of gadolinium contrast agent in hemodialysis patients","volume":"42","author":"Okada","year":"2001","journal-title":"Acta Radiol"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044307004022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044307004022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T18:00:06Z","timestamp":1546970406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044307004022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S1051044307004022"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2007.01.025","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}